Edition:
United Kingdom

Core Laboratories NV (CLB.N)

CLB.N on New York Stock Exchange

64.46USD
9:04pm BST
Change (% chg)

$-8.49 (-11.64%)
Prev Close
$72.95
Open
$70.35
Day's High
$70.35
Day's Low
$64.45
Volume
222,645
Avg. Vol
113,875
52-wk High
$130.34
52-wk Low
$56.84

Latest Key Developments (Source: Significant Developments)

Core Laboratories NV Reports Qtrly GAAP EPS Of $0.90
Wednesday, 24 Apr 2019 

April 24 (Reuters) - Core Laboratories NV ::CORE LABORATORIES NV QTRLY GAAP EPS OF $0.90.CORE LABORATORIES NV QTRLY REVENUE $169.2 MILLION VERSUS $170 MILLION.CORE LABORATORIES NV - EXPECTS CONSOLIDATED Q2 2019 REVENUE OF ABOUT $172 MILLION TO $175 MILLION AND OPERATING INCOME OF ABOUT $28.5 MILLION TO $30 MILLION.CORE LABORATORIES NV - USING COMPARABLE SEQUENTIAL EFFECTIVE TAX RATE OF 15%, EPS FOR Q2 2019 IS EXPECTED TO BE ABOUT $0.47 TO $0.50.  Full Article

Core Lab Reports Q4 EPS $0.49
Thursday, 1 Feb 2018 

Jan 31 (Reuters) - Core Laboratories Nv ::CORE LAB REPORTS FOURTH QUARTER 2017 RESULTS:.INITIATES Q1 2018 EPS GUIDANCE IN-LINE WITH TYPICAL SEASONAL PATTERNS.‍Q4 2017 REVENUE OF $171.9 MILLION UP 15 PCT YEAR-OVER-YEAR​.PROJECTS Q1 2018 REVENUE OF APPROXIMATELY $168 MILLION TO $172 MILLION.QTRLY DILUTED EARNINGS PER SHARE $0.49.EPS FOR Q1 2018 IS EXPECTED TO BE APPROXIMATELY $0.56 TO $0.58.Q1 EARNINGS PER SHARE VIEW $0.61, REVENUE VIEW $174.5 MILLION -- THOMSON REUTERS I/B/E/S.Q4 EARNINGS PER SHARE VIEW $0.58, REVENUE VIEW $171.6 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Core Laboratories qtrly ‍revenue $166.2 mln vs $143.5 mln
Monday, 23 Oct 2017 

Oct 23 (Reuters) - Core Laboratories NV : :Core Laboratories NV qtrly ‍revenue $166.2 million versus $143.5 million.Core Laboratories NV - qtrly earnings per share $0.48‍​.Core Laboratories NV - ‍eps for q4 2017 is expected to be approximately $0.58​.Core Laboratories NV sees Q4 2017 revenue of approximately $171.5 million.Q4 earnings per share view $0.58, revenue view $171.3 million -- Thomson Reuters I/B/E/S.Q3 earnings per share view $0.44, revenue view $161.4 million -- Thomson Reuters I/B/E/S.  Full Article

Core Lab reports qtrly earnings per share $0.52
Tuesday, 25 Jul 2017 

July 24 (Reuters) - Core Laboratories NV :Core Lab reports second quarter 2017 results:.Core Laboratories NV - Q2 2017 revenue of $164 million , up 4% sequentially from its Q1 2017 revenue.Qtrly earnings per share $0.52.Company projects that its operating income in Q3 is expected to range between $30.9 million and $33.5 million.EPS for Q3 is expected to range between $0.54 and $0.56..Q3 earnings per share view $0.61 -- Thomson Reuters I/B/E/S.Core Laboratories NV - Core projects Q3 2017 revenue of approximately $166 million to $170 million.Q3 revenue view $179.5 million -- Thomson Reuters I/B/E/S.  Full Article

Core Laboratories Q2 profit of 52 cents/shr
Monday, 24 Jul 2017 

July 24 (Reuters) - Core Laboratories Nv ::Core Laboratories NV - q2 2017 revenue of $163.9 million, up 4 pct sequentially from its q1 2017 revenue.Core Laboratories NV qtrly earnings per diluted share of $0.51.Core Laboratories NV qtrly ex-fx eps of $0.52.Core Laboratories - core projects q3 2017 revenue of approximately $165.5 million to $170 million.Core Laboratories - projects operating income in q3 is expected to range between $30.9 million and $33.5 million.Core Laboratories nv - eps for q3 is expected to range between $0.54 and $0.56.Core Laboratories - q3 2017 fcf is expected to exceed net income.Q2 earnings per share view $0.51, revenue view $168.5 million -- Thomson Reuters I/B/E/S.Q3 earnings per share view $0.61, revenue view $179.5 million -- Thomson Reuters I/B/E/S.  Full Article

Photo

Greenlight's Einhorn tweaks portfolio, says CFO to leave

NEW YORK Hedge fund manager David Einhorn, whose Greenlight Capital suffered its worst year ever in 2018, told investors on Wednesday he had made some changes to the fund's main portfolio, including selling Bayer , Mylan and Perrigo last year.